Abbott Laboratories (ABT)
SIX
Closed
Aug 21, 2026
Day's Range
93.0052 wk Range
65.00Overview - ABT - Abbott Laboratories
Key Statistics
Valuation
Enterprise Value
150.77B
P/E (Trailing)
‪29.47‬
PEG Ratio
‪-0.61‬
Price / Sales (TTM)
‪2.69‬
Price / Book
‪3.07‬
EV / EBITDA
‪16.15‬
Profitability
Profit Margin
‪11.64%‬
Operating Margin
‪14.70%‬
Return on Assets
‪5.32%‬
Return on Equity
‪10.57%‬
Ownership
Shares Outstanding
1.73B
Float
1.71B
Held by Insiders
‪0.49%‬
Held by Institutions
‪81.88%‬
Price stats
Beta
‪0.58‬
50-Day Avg
‪80.56‬
200-Day Avg
‪85.53‬
Dividends
Payout Ratio
‪78.96%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ABT - Abbott Laboratories
Peers - ABT - Abbott Laboratories
Peer Comparison
Compared with companies in Medical Devices listed on SIX.
Profile Summary - ABT - Abbott Laboratories
About
Abbott Laboratories is a diversified healthcare company that discovers, develops, manufactures, and sells a comprehensive range of medical products and pharmaceuticals globally. The company operates through four primary segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
